(Press-News.org) Magnetic fields produced by the naturally occurring electrical currents in the brain could potentially be used as an objective test for schizophrenia and help to better understand the disease, according to new research published today.
A team of researchers from Plymouth and Spain have used the non-invasive magnetoencephalogram (MEG) technique to find two spectral features that are significantly different in schizophrenia patients compared to healthy control subjects.
Furthermore, they found that there were four spectral features in the brain signals of schizophrenia patients that changed with age compared to healthy control subjects, suggesting that schizophrenia affects the way in which brain activity evolves with age.
The study has been published today, Thursday 31 January, in the journal Physiological Measurement.
Schizophrenia is a serious psychiatric disorder, usually starting in late adolescence, which is characterised by a range of positive and negative symptoms, including hallucinations, delusions, paranoia, cognitive impairment, social withdrawal, self-neglect and loss of motivation and initiative.
It has no objective test and is currently diagnosed by clinicians who assess patients using a defined set of criteria.
Lead author of the study Dr Javier Escudero said: "At present, there is no blood, cerebrospinal fluid, brain imaging or neurophysiological test for schizophrenia in routine clinical practice. The diagnosis relies on the interpretation of symptoms and clinical history according to consensus criteria.
"The advent of an objective marker for schizophrenia would significantly facilitate the diagnosis and offer a better understanding of the neurobiological basis of the disease."
In this study, the frequency spectrum of the MEG background activity was analysed in 15 schizophrenia patients with positive symptoms and 17 age-matched healthy control subjects.
A range of spectral features from the MEGs were analysed to provide a holistic view of the brain activity of each subject. The MEG produced 148 values for each subject, which were subsequently divided into five different groups representing different parts of the brain, and were statistically analysed.
The researchers also investigated whether the spectral features could be used to distinguish between schizophrenia patients and the healthy controls. They showed that they were able to classify patients with 71 per cent accuracy.
"The long-term vision is to develop a low-cost, non-invasive and objective test to aid the diagnosis of this and other brain diseases. The magnetoencephalogram is able to provide very detailed information about the brain activity; however, it is expensive. Therefore, we aim to transfer these developments to electroencephalogram recordings in the future, as this technique meets those requirements of reduced cost, high availability and non-invasiveness," continued Dr Escudero.
###The researchers are from Plymouth University, Universidad Complutense de Madrid, Centro de Tecnología Biomédica, Hospital Universitario San Carlos and University of Valladolid.
From Thursday 31 January, this paper can be downloaded from http://iopscience.iop.org/0967-3334/34/2/265
Notes to Editors
Contact
1. For further information, a full draft of the journal paper or to contact one of the researchers, contact IOP Press Officer, Michael Bishop:
Tel: 0117 930 1032
E-mail: Michael.Bishop@iop.org
Changes in the MEG background activity in patients with positive symptoms of schizophrenia: spectral analysis and impact of age
2. The published version of the paper "Changes in the MEG background activity in patients with positive symptoms of schizophrenia: spectral analysis and impact of age" (Javier Escudero et al 2013 Physiol. Meas. 34 265) will be freely available online from Thursday 31 January at http://iopscience.iop.org/0967-3334/34/2/265 .
Physiological Measurement
3. Physiological Measurement covers the quantitative measurement and visualization of physiological structure and function in clinical research and practice.
IOP Publishing
4. IOP Publishing provides publications through which leading-edge scientific research is distributed worldwide. IOP Publishing is central to the Institute of Physics (IOP), a not-for-profit society. Any financial surplus earned by IOP Publishing goes to support science through the activities of IOP. Beyond our traditional journals programme, we make high-value scientific information easily accessible through an ever-evolving portfolio of community websites, magazines, conference proceedings and a multitude of electronic services. Focused on making the most of new technologies, we're continually improving our electronic interfaces to make it easier for researchers to find exactly what they need, when they need it, in the format that suits them best. Go to http://ioppublishing.org/
The Institute of Physics
5. The Institute of Physics is a leading scientific society. We are a charitable organisation with a worldwide membership of more than 45,000, working together to advance physics education, research and application. We engage with policymakers and the general public to develop awareness and understanding of the value of physics and, through IOP Publishing, we are world leaders in professional scientific communications.
Institute of Physics and Engineering in Medicine
6. IPEM's aim is to promote the advancement of physics and engineering applied to medicine and biology for the public benefit. Its members are professionals working in healthcare, education, industry and research.
IPEM publishes scientific journals and books and organises conferences to disseminate knowledge and support members in their development. It sets and advises on standards for the practice, education and training of scientists and engineers working in healthcare to secure an effective and appropriate workforce.
Brain activity study lends insight into schizophrenia
2013-01-31
ELSE PRESS RELEASES FROM THIS DATE:
Dementia: Cerebrolysin shows promise
2013-01-31
Dementia patients may benefit from a promising new treatment called Cerebrolysin, according to the results of a systematic review published in The Cochrane Library. The authors brought together the most up-to-date evidence on Cerebrolysin as a treatment for vascular dementia.
Vascular dementia is a common form of dementia caused by damage to the network of blood vessels supplying the brain. Some of the symptoms are similar to those associated with Alzheimer's disease and stroke but in particular those with vascular dementia often experience difficulty thinking quickly, ...
Chronic hepatitis C: Interferon may be harmful in re-treatment
2013-01-31
People with hepatitis C and chronic liver disease who relapsed or failed to respond to initial treatment are unlikely to improve on interferon retreatment. In fact, they may face an increased risk of dying sooner, and are likely to experience a variety of adverse effects, according to an updated systematic review published in The Cochrane Library.
Hepatitis C affects around 170 million people worldwide. In some cases, infection leads to chronic liver disease, liver failure or liver cancer, eventually resulting in death. Treatment is based on antiviral drugs.
Interferon ...
Tuberculosis: WHO-endorsed test offers rapid detection
2013-01-31
A diagnostic test for tuberculosis (TB) can accurately and quickly detect both TB and drug-resistant strains, according to a new study. The authors of a new systematic review assessing the diagnostic accuracy of the Xpert® MTB/RIF test published in The Cochrane Library say their study can provide timely advice for clinicians and policymakers in countries where TB is a major public health problem.
Millions of people develop TB every year. Around 13% of cases occur in people living with HIV and more than a quarter of these people die as a result. Drug resistance is a major ...
New research shows complexity of global warming
2013-01-31
Global warming from greenhouse gases affects rainfall patterns in the world differently than that from solar heating, according to a study by an international team of scientists in the January 31 issue of Nature. Using computer model simulations, the scientists, led by Jian Liu (Chinese Academy of Sciences) and Bin Wang (International Pacific Research Center, University of Hawaii at Manoa), showed that global rainfall has increased less over the present-day warming period than during the Medieval Warm Period, even though temperatures are higher today than they were then. ...
Tuberculosis may lurk in bone marrow stem cells of infected patients, Stanford researchers say
2013-01-31
STANFORD, Calif. - Tuberculosis is a devastating disease that kills nearly 2 million people worldwide each year. Although antibiotics exist that can ameliorate the symptoms, the courses of therapy last for months and don't completely eradicate the disease, which frequently recurs years or decades after the initial treatment.
Now, in a classic case of bench-to-bedside research, scientists at the Stanford University School of Medicine have discovered a possible reason for the disease's resistance: The ability of the tuberculosis bacteria to infiltrate and settle down in ...
Arunachal contributes in detecting stem cells where dormant TB bacteria hide
2013-01-31
The Idu-Mishmi community and Arunachal Pradesh appeared on the world map today for its greatest contribution in studying dormant Mycobacterium in TB that has affected nearly 4 billion people in the world and causing 1.9 million deaths yearly. In India, one person is dying of TB every 3 minutes. The study details and the contribution of Idu-Mishmis of Arunachal Pradesh and RIWATCH (Research Institute of World's Ancient Traditions Cultures and Heritage) in accomplishing the study has been duly acknowledged in a research paper published in a reputed journal 'Science Translational ...
Tenofovir Gel wins out in drug absorption study, but HIV prevention trials say differently
2013-01-31
PITTSBURGH, Jan. 30, 2012 –A novel head-to-head study looking at differences in how the antiretroviral (ARV) drug tenofovir gets absorbed in the body as either an oral tablet or a vaginal gel found tenofovir gel can achieve substantially higher concentrations of active drug in vaginal tissue than the oral tablet, suggesting that tenofovir gel should be highly effective in protecting women against HIV transmitted through vaginal sex. Yet, as unequivocal as the study's results may be, they have not been borne out in HIV prevention trials to date, leading the researchers to ...
Antibiotics cut death rate for malnourished children
2013-01-31
Severely malnourished children are far more likely to recover and survive when given antibiotics along with a therapeutic peanut-based food than children who are simply treated with the therapeutic food alone, researchers at Washington University School of Medicine in St. Louis have found.
"The findings are remarkable," says Indi Trehan, MD, lead author of the research, published Jan. 31 in The New England Journal of Medicine. "Based on previous research, we didn't think there would be much benefit from antibiotics. We did not at all expect to see a drop in the death ...
Vultures foraging far and wide face a poisonous future
2013-01-31
A first ever study of the range and habits of white-backed vultures across southern Africa shows that they often shun national parks, preferring to forage further afield on private farmland.
This behaviour and their tendency to scavenge in groups, means that vultures risk encountering dead cattle that have been administered veterinary drugs that are poisonous to them, or even poisoned carcasses intended to control other carnivores such as jackals.
The research, using Global Positioning System (GPS) satellite transmitters to track the movements of adolescent vultures, ...
Exposure to antiepileptic drug in womb linked to autism risk
2013-01-31
Children whose mothers take the antiepileptic drug sodium valproate while pregnant are at significantly increased risk of autism and other neurodevelopmental disorders, suggests a small study published online in the Journal of Neurology Neurosurgery and Psychiatry.
The authors base their findings on children born to 528 pregnant women between 2000 and 2004 in the North West of England.
Just fewer than half the mums (243) had epilepsy, all but 34 of whom took antiepileptic drugs during their pregnancy. Fifty nine mums took carbamazepine; 59 took valproate; 36 took lamotrigine; ...